Venous thromboembolism in medical outpatients - A cross-sectional survey of risk assessment and prophylaxis

Thrombosis and Haemostasis

Volumn 105, Issue 1, 2011, Pages 190-196

  Lawall, Holger ^a   Matthiessen, Andreas ^b   Hohmann, Volker ^c   Bramlage, Peter ^d   Haas, Sylvia ^e   Schellong, Sebastian ^f  

^a Klinikum Karlsbad Langensteinbach   (Germany)

^b Praxis   (Germany)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^d Institute for Cardiovascular Pharmacology and Epidemiology   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

Author keywords

Dispositional risk; Enoxaparin; Expositional risk; Risk assessment; Scorecard; Venous thromboembolism

Indexed keywords

ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE DISEASE; ADULT; AGE DISTRIBUTION; AGED; ANTICOAGULANT THERAPY; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HAAS SCORECARD; HEART FAILURE; HUMAN; IMMOBILIZATION; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTPATIENT; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SEX RATIO; VARICOSIS; VENOUS THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DECISION MAKING; DECISION MAKING, COMPUTER-ASSISTED; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PREMEDICATION; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 78651082300     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-03-0191     Document Type: Article

References (29)

1. Goldhaber SZ, Fanikos J. Cardiology patient pages. Prevention of deep vein thrombosis and pulmonary embolism. Circulation 2004; 110: e445-447.
2. Anderson FA, Jr., Zayaruzny M, Heit JA, et al. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol 2007; 82: 777-782.
3. Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001; 86: 452-463.
4. Bauersachs RM, Riess H, Hach-Wunderle V, et al. Impact of gender on the clinical presentation and diagnosis of deep-vein thrombosis. Thromb Haemost 2010; 103: 710-717.
5. Bergmann JF, Cohen AT, Tapson VF, et al. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey. Thromb Haemost 2010; 103: 736-748.
6. Spencer FA, Gore JM, Reed G, et al. Venous thromboembolism and bleeding in a community setting. The Worcester Venous Thromboembolism Study. Thromb Haemost 2009; 101: 878-885.
7. Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98: 756-764.
8. Tapson VF, Decousus H, Pini M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest 2007; 132: 936-945.
9. Yu HT, Dylan ML, Lin J, et al. Hospitals' compliance with prophylaxis guidelines for venous thromboembolism. Am J Health Syst Pharm 2007; 64: 69-76. (Pubitemid 46395711)
10. Lawall H, Hoffmanns W, Hoffmanns P, et al., Prevalence of deep vein thrombosis (DVT) in non-surgical patients at hospital admission. Thromb Haemost 2007; 98: 765-770.
11. Zotz RB, Kauschat-Bruning D, Bramlage P. Thromboembolic risk and prophylaxis in hospitalized surgical and internal medicine patients. German results of the international ENDORSE study. Dtsch Med Wochenschr 2009; 134: 2163-2169.
12. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008; 371: 387-394.
13. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 381S-453S.
14. Anderson FA, Jr., Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991; 151: 933-938.
15. Spencer FA, Lessard D, Emery C, et al. Venous thromboembolism in the outpatient setting. Arch Intern Med 2007; 167: 1471-1475.
16. Heit JA, O'Fallon WM, Petterson TM, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002; 162: 1245-1248.
17. Laporte S, Mismetti P. Epidemiology of thrombotic risk factors: the difficulty in using clinical trials to develop a risk assessment model. Crit Care Med 2010; 38: S10-17.
18. Caprini JA, Arcelus JI, Reyna JJ. Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol 2001; 38: 12-19.
19. Russell MW, Taylor DC, Cummins G, et al. Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients. Am J Manag Care 2002; 8: S3-9.
20. Cohen AT, Alikhan R, Arcelus JI, et al. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost 2005; 94: 750-759.
21. Haas S. Assessment of thromboembolic risk in internal medicine patients. Phlebologie 2005; 34: 87-93. (Pubitemid 40562543)
22. Samama MM, OE Dahl, P Mismetti, et al., An electronic tool for venous thromboembolism prevention in medical and surgical patients. Haematologica 2006; 91: 64-70.
23. Samama MM, An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 2000; 160: 3415-3420.
24. Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160: 809-815.
25. Haas SK, Hach-Wunderle V, Mader FH, et al. An evaluation of venous thromboembolic risk in acutely ill medical patients immobilized at home: the AT-HOME Study. Clin Appl Thromb Hemost 2007; 13: 7-13.
26. Lutz L, Haas S, Hach-Wunderle V, et al. Venöse Thromboembolie in der Inneren Medizin: Risikoeinschätzung und medikamentöse Prophylaxe. Med Welt 2002; 53: 231-234.
27. Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999; 341: 793-800.
28. Kahn SR, A Panju, W Geerts, et al., Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res 2007; 119: 145-155.
29. Haas SK, Kroeger K, Regitz-Zagrosek V, et al. Evaluation of venous thromboembolic risk profiles in acutely ill medical patients in hospital and outpatient settings: the STATUS registry. J Thromb Haemost 2007; 5: P-M-540.